Olivia M Dong
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 10, 2025
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review.Olivia M Dong, Na'ngono Manga, Yue Zhong
|Apr 29, 2024
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.William L Herring, Meghan E Gallagher, Nirmish Shah
|Jun 02, 2022
Cost-effectiveness of CYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes.Olivia M Dong, Kevin A Friede, Catherine Chanfreau-Coffinier
|Oct 27, 2021
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites.Olivia M Dong, Megan C Roberts, R Ryanne Wu
|Jan 06, 2021
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.Olivia M Dong, Jill Bates, Catherine Chanfreau-Coffinier
|Oct 27, 2018
Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping.Amber Frick, Cristina Benton, Oscar Suzuki
Pageof 1
